Literature DB >> 2822190

Differential sensitivity of models of antinociception in the rat, mouse and guinea-pig to mu- and kappa-opioid receptor agonists.

A G Hayes1, M J Sheehan, M B Tyers.   

Abstract

1 A range of opioid receptor agonists were tested for activity in five antinociceptive models: the acetylcholine-induced abdominal constriction, tail-flick and hot plate tests in the mouse and the paw pressure test in the rat and guinea-pig. 2 Agonists acting preferentially at the kappa-opioid receptor were significantly more potent in the guinea-pig than in the rat paw pressure test, whereas mu-receptor preferring agonists were equipotent in the two tests. The mouse abdominal constriction test was of equal sensitivity to the guinea-pig pressure test for both types of agonist. 3 The mouse tail-flick and hot plate tests were progressively less sensitive than the other three tests, particularly to kappa-receptor preferring agonists. 4 The efficacy of an agonist can also markedly affect its activity in antinociceptive tests. Thus, partial kappa-agonists were weak or inactive in the rat paw pressure test, and partial agonists at both mu- and kappa-opioid receptors were relatively weak in the tests in which heat was the noxious stimulus, particularly the mouse hot plate test. 5 The mouse abdominal constriction test is suggested as the most appropriate antinociceptive model for testing a broad range of opioid agonists, whilst the relative potency of a drug in the rat and guinea-pig paw pressure tests may indicate the degree to which it is selective for kappa-opioid receptors in vivo.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2822190      PMCID: PMC1853585          DOI: 10.1111/j.1476-5381.1987.tb11281.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  A classification of opiate receptors that mediate antinociception in animals.

Authors:  M B Tyers
Journal:  Br J Pharmacol       Date:  1980-07       Impact factor: 8.739

2.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

Authors:  W R Martin; C G Eades; J A Thompson; R E Huppler; P E Gilbert
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

3.  Pharmacology of delta-opioid receptors in the hamster vas deferens.

Authors:  M J Sheehan; A G Hayes; M B Tyers
Journal:  Eur J Pharmacol       Date:  1986-10-14       Impact factor: 4.432

4.  Differences in antiwrithing activity of morphine and nalorphine over time and in slopes of the dose-response lines.

Authors:  J Pearl; M D Aceto; J J Fitzgerald
Journal:  Psychopharmacologia       Date:  1968

5.  Differentiation of potent mu and kappa-opiate agonists using heat and pressure antinociceptive profiles and combined potency analysis.

Authors:  N Upton; R D Sewell; P S Spencer
Journal:  Eur J Pharmacol       Date:  1982-03-26       Impact factor: 4.432

6.  The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties.

Authors:  J Magnan; S J Paterson; A Tavani; H W Kosterlitz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-06       Impact factor: 3.000

7.  Rabbit vas deferens: a specific bioassay for opioid kappa-receptor agonists.

Authors:  T Oka; K Negishi; M Suda; T Matsumiya; T Inazu; M Ueki
Journal:  Eur J Pharmacol       Date:  1981-07-17       Impact factor: 4.432

8.  Spectrum of the mu, delta- and kappa-binding sites in homogenates of rat brain.

Authors:  M G Gillan; H W Kosterlitz
Journal:  Br J Pharmacol       Date:  1982-11       Impact factor: 8.739

9.  Endogenous opioid peptides: multiple agonists and receptors.

Authors:  J A Lord; A A Waterfield; J Hughes; H W Kosterlitz
Journal:  Nature       Date:  1977-06-09       Impact factor: 49.962

10.  Characterization of the kappa-subtype of the opiate receptor in the guinea-pig brain.

Authors:  H W Kosterlitz; S J Paterson; L E Robson
Journal:  Br J Pharmacol       Date:  1981-08       Impact factor: 8.739

View more
  23 in total

1.  Effects of yohimbine on the antinociceptive and place conditioning effects of opioid agonists in rodents.

Authors:  L Morales; C Perez-Garcia; L F Alguacil
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  Phytochemical characterization and antinociceptive effect of Lippia gracilis Schauer.

Authors:  Adriana G Guimarães; Silvana V F Gomes; Valéria R S Moraes; Paulo C L Nogueira; Antônio G Ferreira; Arie F Blank; Alan D C Santos; Monalisa D Viana; Geraldo H Silva; Lucindo J Quintans Júnior
Journal:  J Nat Med       Date:  2011-10-22       Impact factor: 2.343

3.  Neuroprotective actions of GR89696, a highly potent and selective kappa-opioid receptor agonist.

Authors:  P J Birch; H Rogers; A G Hayes; N J Hayward; M B Tyers; D I Scopes; A Naylor; D B Judd
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

4.  Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration.

Authors:  C G Parsons; D C West; P M Headley
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

5.  Discriminative stimulus effects of spiradoline, a kappa-opioid agonist.

Authors:  S G Holtzman; L Cook; G F Steinfels
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

6.  Effects of the delta opioid against BW373U86 in pigeons trained to discriminate fentanyl, bremazocine and water in a three-choice drug discrimination procedure.

Authors:  S S Negus; D Morgan; C D Cook; M J Picker
Journal:  Psychopharmacology (Berl)       Date:  1996-08       Impact factor: 4.530

7.  Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay.

Authors:  J H Broadbear; S S Negus; E R Butelman; B R de Costa; J H Woods
Journal:  Psychopharmacology (Berl)       Date:  1994-07       Impact factor: 4.530

8.  Spinal antinociceptive actions of mu- and kappa-opioids: the importance of stimulus intensity in determining 'selectivity' between reflexes to different modalities of noxious stimulus.

Authors:  C G Parsons; P M Headley
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

9.  Differential cross-tolerance to mu and kappa opioid agonists in morphine-tolerant rats responding under a schedule of food presentation.

Authors:  M J Picker; S S Negus; K R Powell
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

10.  Standardization of the rat paw formalin test for the evaluation of analgesics.

Authors:  H Wheeler-Aceto; A Cowan
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.